Asymptomatic volunteers with a polycystic ovary are a functionally distinct but heterogeneous population

Journal of Clinical Endocrinology and Metabolism

Volumn 94, Issue 5, 2009, Pages 1579-1586

  Mortensen, Monica ^a   Ehrmann, David A ^a   Littlejohn, Elizabeth ^a   Rosenfield, Robert L ^a,b  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; GONADORELIN AGONIST; HYDROXYPROGESTERONE; TESTOSTERONE; ESTRADIOL; FOLLITROPIN; GONADORELIN; LUTEINIZING HORMONE; PRASTERONE SULFATE;

ADOLESCENT; ADULT; ARTICLE; CHILD; CONTROLLED STUDY; CORTICOTROPIN TEST; FEMALE; HUMAN; MAJOR CLINICAL STUDY; ORAL GLUCOSE TOLERANCE TEST; OVARIAN FUNCTION TEST; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; SCHOOL CHILD; TESTOSTERONE BLOOD LEVEL; ANOVULATION; BLOOD; BODY MASS; DRUG POTENTIATION; ECHOGRAPHY; HYPERANDROGENISM; OVARY; PATHOPHYSIOLOGY; PELVIS; PHENOTYPE; PRESCHOOL CHILD; PROSPECTIVE STUDY;

17-ALPHA-HYDROXYPROGESTERONE; ADOLESCENT; ADRENOCORTICOTROPIC HORMONE; ADULT; ANOVULATION; BODY MASS INDEX; CHILD, PRESCHOOL; DEHYDROEPIANDROSTERONE SULFATE; ESTRADIOL; FEMALE; FOLLICLE STIMULATING HORMONE; GONADOTROPIN-RELEASING HORMONE; HUMANS; HYPERANDROGENISM; LUTEINIZING HORMONE; OVARY; PELVIS; PHENOTYPE; POLYCYSTIC OVARY SYNDROME; PROSPECTIVE STUDIES; TESTOSTERONE; YOUNG ADULT;

EID: 66149098584     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2008-2771     Document Type: Article

References (35)

1. Ehrmann DA, Barnes RB, Rosenfield RL 1995 Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion. Endocr Rev 16:322-353
2. Zawadzki J, Dunaif A 1992 Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In: Dunaif A, Givens J, Haseltine F, Merriam G, eds. Polycystic ovary syndrome. Cambridge, MA: Blackwell Scientific Publications; 377-384
3. Taylor AE, McCourt B, Martin KA, Anderson EJ, Adams JM, Schoenfeld D, Hall JE 1997 Determinants of abnormal gonadotropin secretion in clinically defined women with polycystic ovary syndrome. J Clin Endocrinol Metab 82:2248-2256 (Pubitemid 27287593)
4. Legro RS, Chiu P, Kunselman AR, Bentley CM, Dodson WC, Dunaif A 2005 Polycystic ovaries are common in women with hyperandrogenic chronic anovulation but do not predict metabolic or reproductive phenotype. J Clin Endocrinol Metab 90:2571-2579 (Pubitemid 40686293)
5. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group 2004 Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81:19-25 (Pubitemid 38058321)
6. Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, Janssen OE, Legro RS, Norman RJ, Taylor AE, Witchel SF, Task Force on the Phenotype of the Polycystic Ovary Syndrome of The Androgen Excess and PCOS Society 2009 The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril 91:456-488
7. Polson D, Adams J, Wadsworth J, Franks S 1988 Polycystic ovaries - a common finding in normal women. Lancet 1:870-872 (Pubitemid 18092411)
8. Clayton RN, Ogden V, Hodgkinson J, Worswick L, Rodin DA, Dyer S, Meade TW 1992 How common are polycystic ovaries in normal women and what is their significance for the fertility of the population. Clin Endocrinol (Oxf) 37:127-134
9. Farquhar CM, Birdsall M, Manning P, Mitchell JM, France JT 1994 The prevalence of polycystic ovaries on ultrasound scanning in a population of randomly selected women. Aust N Z J Obstet Gynaecol 34:67-72 (Pubitemid 24061513)
10. van Hooff MH, Voorhorst FJ, Kaptein MB, Hirasing RA, Koppenaal C, Schoemaker J 2000 Polycystic ovaries in adolescents and the relationship with menstrual cycle patterns, luteinizing hormone, androgens, and insulin. Fertil Steril 74:49-58 (Pubitemid 30427272)
11. Gilling-Smith C, Story H, Rogers V, Franks S 1997 Evidence for a primary abnormality of thecal cell steroidogenesis in the polycystic ovary syndrome. Clin Endocrinol (Oxf) 47:93-99 (Pubitemid 27313994)
12. Chang PL, Lindheim SR, Lowre C, Ferin M, Gonzalez F, Berglund L, Carmina E, Sauer MV, Lobo RA 2000 Normal ovulatory women with polycystic ovaries have hyperandrogenic pituitary-ovarian responses to gonadotropin-releasing hormone-agonist testing. J Clin Endocrinol Metab 85:995-1000 (Pubitemid 32269339)
13. Adams JM, Taylor AE, Crowley Jr WF, Hall JE 2004 Polycystic ovarian morphology with regular ovulatory cycles: insights into the pathophysiology of polycystic ovarian syndrome. J Clin Endocrinol Metab 89:4343-4350 (Pubitemid 39244436)
14. Rosenfield RL 2005 Clinical practice. Hirsutism. N Engl J Med 353:2578-2588
15. Burke JP, Hale DE, Hazuda HP, Stern MP 1999 A quantitative scale of acanthosis nigricans. Diabetes Care 22:1655-1659 (Pubitemid 29458388)
16. Mortensen M, Rosenfield RL, Littlejohn E 2006 Functional significance of polycystic-size ovaries in healthy adolescents. J Clin Endocrinol Metab 91: 3786-3790 (Pubitemid 44536844)
17. Moll Jr G, Rosenfield R 1979 Testosterone binding and free plasma androgen concentrations under physiological conditions: characterization by flow dialysis technique. J Clin Endocrinol Metab 49:730-736 (Pubitemid 10198306)
18. Rosenfield RL, Perovic N, Ehrmann DA, Barnes RB 1996 Acute hormonal responses to the gonadotropin releasing hormone agonist leuprolide: doseresponse studies and comparison to nafarelin-a clinical research center study. J Clin Endocrinol Metab 81:3408-3411 (Pubitemid 26296224)
19. Rosenfield RL, Barnes RB, Ehrmann DA 1994 Studies of the nature of 17- hydroxyprogesterone hyperresponsiveness to gonadotropin releasing hormone agonist challenge in functional ovarian hyperandrogenism. J Clin Endocrinol Metab 79:1686-1692
20. Morgan CR, Lazarow A 1963 Immunoassay of insulin: two antibody system. Plasma insulin levels of normal, subdiabetic, and diabetic rats. Diabetes 12: 115-126
21. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC 1985 Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419 (Pubitemid 15018832)
22. Matsuda M, DeFronzo RA 1999 Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22:1462-1470 (Pubitemid 29418240)
23. Balen AH, Laven JS, Tan SL, Dewailly D 2003 Ultrasound assessment of the polycystic ovary: international consensus definitions. Hum Reprod Update 9:505-514 (Pubitemid 38072143)
24. Adams J, Franks S, Polson DW, Mason HD, Abdulwahid NA, Tucker M, Morris DV, Price J, Jacobs HS 1985 Multifollicular ovaries: clinical and endocrine features and response to pulsatile gonadotrophin releasing hormone. Lancet 2:1375-1378 (Pubitemid 16138549)
25. Altman DG 1999 Practical statistics for medical research. Boca Raton, FL: Chapman, Hall/CRC Press
26. Murphy MK, Hall JE, Adams JM, Lee H, Welt CK 2006 Polycystic ovarian morphology in normal women does not predict the development of polycystic ovary syndrome. J Clin Endocrinol Metab 91:3878-3884 (Pubitemid 44536858)
27. Nelson VL, Legro RS, Strauss 3rd JF, McAllister JM 1999 Augmented androgen production is a stable steroidogenic phenotype of propagated theca cells from polycystic ovaries. Mol Endocrinol 13:946-957 (Pubitemid 30645312)
28. Gilling-Smith C, Willis DS, Beard RW, Franks S 1994 Hypersecretion of androstenedione by isolated theca cells from polycystic ovaries. J Clin Endocrinol Metab 79:1158-1165 (Pubitemid 24342265)
29. Carey AH, Chan KL, Short F, White D, Williamson R, Franks S 1993 Evidence for a single gene effect causing polycystic ovaries and male pattern baldness. Clin Endocrinol (Oxf) 38:653-658 (Pubitemid 23168483)
30. Govind A, Obhrai MS, Clayton RN 1999 Polycystic ovaries are inherited as an autosomal dominant trait: analysis of 29 polycystic ovary syndrome and 10 control families. J Clin Endocrinol Metab 84:38-43 (Pubitemid 29036677)
31. Lyet L, Louis F, Forest MG, Josso N, Behringer RR, Vigier B 1995 Ontogeny of reproductive abnormalities induced by deregulation of anti-mullerian hormone expression in transgenic mice. Biol Reprod 52:444-454
32. Carlsson IB, Scott JE, Visser JA, Ritvos O, Themmen AP, Hovatta O 2006 Anti-Müllerian hormone inhibits initiation of growth of human primordial ovarian follicles in vitro. Hum Reprod 21:2223-2227 (Pubitemid 44530593)
33. Steckler TL, Herkimer C, Dumesic DA, PadmanabhanV2009 Developmental programming: excess weight gain amplifies the effects of prenatal testosterone excess on reproductive cyclicity - implication to PCOS. Endocrinology 150: 1456-1465
34. Robinson S, Kiddy D, Gelding S, Willis D, Niththyananthan R, Bush A, Johnson DG 1993 The relationship of insulin insensitivity to menstrual pattern in women with hyperandrogenism and polycystic ovaries. Clin Endocrinol (Oxf) 39:351-355 (Pubitemid 23274435)
35. Pasquali R, Patton L, Pocognoli P, Cognigni GE, Gambineri A 2007 17-Hydroxyprogesterone responses to gonadotropin-releasing hormone disclose distinct phenotypes of functional ovarian hyperandrogenism and polycystic ovary syndrome. J Clin Endocrinol Metab 92:4208-4217 (Pubitemid 350074733)